Literature DB >> 18610736

Role of transporter genes in cisplatin resistance.

V Badireenath Konkimalla1, Bernd Kaina, Thomas Efferth.   

Abstract

The 50% inhibitory concentration (IC50) values for cisplatin from 60 cell lines of the National Cancer Institute (NCI), USA, were correlated with the microarray-based mRNA expression levels of 55 transporter genes. The transporters are known to be involved in multiple drug resistance and belong to different classes, e.g. lysosomal H+ transporting ATPases, Cu2+ transporting ATPases, glutamate transporters of the solute carrier family 31, copper transporters of the solute carrier family 31, and ATP-binding cassette (ABC) transporter genes. The expression levels of 17 genes represented by 21 clones correlated significantly with the IC50 values for cisplatin. Hierarchical cluster analysis further enabled the prediction of the sensitivity or resistance of these cell lines to cisplatin with respect to the mRNA expression of these set of transporter genes under study. One among the 17 genes studied is ATP7B which is involved in the transport of copper ions across the cell membrane into the cell. We conclude that our microarray-based approach is a feasible and effective tool in identifying prognostic markers for drug resistance in antitumor therapy.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18610736

Source DB:  PubMed          Journal:  In Vivo        ISSN: 0258-851X            Impact factor:   2.155


  6 in total

1.  RAB8 enhances TMEM205-mediated cisplatin resistance.

Authors:  Ding-Wu Shen; Michael M Gottesman
Journal:  Pharm Res       Date:  2011-10-04       Impact factor: 4.200

2.  DNA Copy Number Aberrations and Expression of ABC Transporter Genes in Breast Tumour: Correlation with the Effect of Neoadjuvant Chemotherapy and Prognosis of the Disease.

Authors:  Matvey M Tsyganov; Marina K Ibragimova; Kseniya A Gaptulbarova; Irina A Tsydenova; Daria S Dolgasheva; Evgeniy Y Garbukov; Anastasia A Frolova; Elena M Slonimskaya; Nikolai V Litvyakov
Journal:  Pharmaceutics       Date:  2022-04-27       Impact factor: 6.525

Review 3.  Platinum resistance in breast and ovarian cancer cell lines.

Authors:  Niels Eckstein
Journal:  J Exp Clin Cancer Res       Date:  2011-10-04

Review 4.  Pharmacogenomics of cisplatin sensitivity in non-small cell lung cancer.

Authors:  Maimon C Rose; Elina Kostyanovskaya; R Stephanie Huang
Journal:  Genomics Proteomics Bioinformatics       Date:  2014-10-28       Impact factor: 7.691

5.  Multifaceted Mechanisms of Cisplatin Resistance in Long-Term Treated Urothelial Carcinoma Cell Lines.

Authors:  Margaretha A Skowron; Margarita Melnikova; Joep G H van Roermund; Andrea Romano; Peter Albers; Juergen Thomale; Wolfgang A Schulz; Günter Niegisch; Michèle J Hoffmann
Journal:  Int J Mol Sci       Date:  2018-02-16       Impact factor: 5.923

6.  Microarray-assisted pathway analysis identifies MT1X & NFκB as mediators of TCRP1-associated resistance to cisplatin in oral squamous cell carcinoma.

Authors:  Bo Peng; Yixue Gu; Yan Xiong; Guopei Zheng; Zhimin He
Journal:  PLoS One       Date:  2012-12-10       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.